Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 23-27, January 2009

Ancrod for Acute Ischemic Stroke: A New Dosing Regimen Derived from Analysis of Prior Ancrod Stroke Studies

  • David E. Levy, MD

      Affiliations

    • Neurobiological Technologies Inc, Edgewater, New Jersey
    • Corresponding Author InformationAddress correspondence to David E. Levy, MD, Neurobiological Technologies Inc, 115 River Rd (Suite 171), Edgewater, NJ 07020.
    • ,
  • James Trammel, MS

      Affiliations

    • i3Statprobe, Stonewall, Louisiana
    • ,
  • Warren W. Wasiewski, MD

      Affiliations

    • Neurobiological Technologies Inc, Edgewater, New Jersey
    • ,
  • for the Ancrod Stroke Program (ASP) Study Team

Received 6 May 2008; received in revised form 18 June 2008; accepted 1 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Data and analytical resources used in preparing this manuscript were provided by the current sponsor of ancrod, Neurobiological Technologies Inc.

 Drs. Levy and Wasiewski are employees of and Mr. Trammel is a contractor for Neurobiological Technologies Inc.

PII: S1052-3057(08)00152-3

doi:10.1016/j.jstrokecerebrovasdis.2008.07.009

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 23-27, January 2009

Article Tools

* Image Usage & Resolution